Hepatocellular carcinoma with gastric adenocarcinoma treated with atezolizumab and bevacizumab

Takayoshi Suga; Yuko Kimura; Kensuke Furuya; Hiroko Sato

doi:10.1002/ccr3.7875

Clinical Case Reports (Sep 2023)

Hepatocellular carcinoma with gastric adenocarcinoma treated with atezolizumab and bevacizumab

Takayoshi Suga,
Yuko Kimura,
Kensuke Furuya,
Hiroko Sato

Affiliations

Takayoshi Suga: Department of Gastroenterology Shibukawa Medical Center, National Hospital Organization Shibukawa Gunma Japan
Yuko Kimura: Department of Gastroenterology Shibukawa Medical Center, National Hospital Organization Shibukawa Gunma Japan
Kensuke Furuya: Department of Gastroenterology Shibukawa Medical Center, National Hospital Organization Shibukawa Gunma Japan
Hiroko Sato: Department of Gastroenterology Shibukawa Medical Center, National Hospital Organization Shibukawa Gunma Japan

DOI: https://doi.org/10.1002/ccr3.7875
Journal volume & issue: Vol. 11, no. 9
pp. n/a – n/a

Abstract

Read online

Key Clinical Message Atezolizumab and bevacizumab combination therapy might be one of the treatment options for hepatocellular carcinoma concurrent with gastric adenocarcinoma.

Published in Clinical Case Reports

ISSN: 2050-0904 (Online)
Publisher: Wiley
Country of publisher: United Kingdom
LCC subjects: Medicine: Medicine (General)
Website: https://onlinelibrary.wiley.com/journal/20500904

About the journal

Abstract

Keywords